Taking a systems approach to the identification of novel therapeutic targets and biomarkers

Current Pharmaceutical Biotechnology

Volumn 11, Issue 7, 2010, Pages 721-734

  Dunn, David A ^a   Apanovitch, Donald ^a   Follettie, Max ^b   He, Tao ^b   Ryan, Terence ^b  

^a PFIZER INC   (United States)

^b NONE

Author keywords

Chemical biology; High content screening; Multivariate analysis; Ontological classification; Predictive modeling; Proteomics; Transcriptomics

Indexed keywords

BIOLOGICAL MARKER;

ARTICLE; DRUG DEVELOPMENT; DRUG TARGETING; HIGH THROUGHPUT SCREENING; HUMAN; NONHUMAN; PHENOTYPE; PROTEOMICS; SYSTEMS BIOLOGY; TRANSCRIPTOMICS;

ANIMALS; BIOLOGICAL MARKERS; DRUG DELIVERY SYSTEMS; DRUG DISCOVERY; GENE EXPRESSION PROFILING; GENE TARGETING; HUMANS; PHARMACEUTICAL PREPARATIONS; SIGNAL TRANSDUCTION; SYSTEMS BIOLOGY;

EID: 78649300684     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/138920110792927739     Document Type: Article

References (141)

1. Chanda, S.; Caldwell, J. Fulfilling the promise: drug discovery in the post-genomic era. Drug Discov. Today, 2003, 8(4), 168-174.
2. Ho, R.L.; Lieu, C.A. Systems biology: an evolving approach in drug discovery and development. Drugs R. D., 2008, 9(4), 203-216.
3. Janga, S.C.; Tzakos, A. Structure and organization of drug-target networks: insights from genomic approaches for drug discovery. Mol. Biol. Syst., 2009, 5, 1536-1548.
4. Fishman, M.C.; Porter, J.A. Pharmaceuticals: a new grammar for drug discovery. Nature, 2005, 437, 491-493.
5. Stelling, J.; Sauer, U.; Szallasi S.; Doyle, F. J. 3rd.; Doyle, J. Robustness of cellular functions. Cell, 2004, 118(6), 675-685.
6. Hood, L.; Perlmutter, R.M. The impact of systems approaches on biological problems in drug discovery. Nat. Biotechnol., 2004, 22, 1215-1217.
7. Butcher, E.C. Can cell systems biology rescue drug discovery? Nat. Rev. Drug Discov., 2005, 4(6), 461-467.
8. Hopkins, A.L. Network pharmacology: the next paradigm in drug discovery. Nat. Chem. Biol., 2008, 4(11), 682-690.
9. Heitzler, D.; Crépieux, P.; Poupon, A.; Clément, F.; Fages, F.; Reiter, E. Towards a systems biology approach of G protein-coupled receptor signaling: challenges and expectations. C. R. Biol., 2009, 332(11), 947-957.
10. Johnson, Z.; Power, C.A.; Weiss, C.; Rintelen, F.; Ji, H.; Ruckle, T.; Camps, M.; Wells, T.N.; Schwarz, M.K.; Proudfoot, A.E.; Rommel, C. Chemokine inhibition-why, when, where, which and how? Biochem. Soc. Trans., 2004, 32(Pt 2), 366-377.
11. Germano, S.; O'Driscoll, L. Breast cancer: understanding sensitivity and resistance to chemotherapy and targeted therapies to aid in personalised medicine. Curr. Cancer Drug Targets, 2009, 9(3), 398-418.
12. Faratian, D.; Goltsov, A.; Lebedeva, G.; Sorokin, A.; Moodie, S.; Mullen, P.; Kay, C.; Um, I. H.; Langdon, S.; Goryanin I.; Harrison D.J. Systems biology reveals new strategies for personalizing cancer medicine and confirms the role of PTEN in resistance to trastuzumab. Cancer Res., 2009, 69(16), 6713-6720.
13. Butcher, E. C.; Berg, E. L.; Kunkel, E. J. Systems biology in drug discovery. Nat. Biotechnol., 2004, 22(10),1253-1259.
14. Cho, C.R.; Labow, M.; Reinhardt, M.; van Oostrum, J.; Peitsch, M.C. The application of systems biology to drug discovery. Curr. Opin. Chem. Biol., 2006, 10(4), 294-302.
15. Zhu, J.; Zhang, B.; Schadt, E.E. A systems biology approach to drug discovery. Adv. Genet., 2008, 60, 603-635.
16. Smith, J.C.; Figeys, D.; Proteomics technology in systems biology. Mol. Biosyst., 2006, 2(8), 364-370.
17. Bernas, T.; Grégori, G.; Asem, E.K.; Robinson J.P. Integrating cytomics and proteomics. Mol. Cell Proteomics, 2006, 5(1), 2-13.
18. Rochfort, S. Metabolomics reviewed: a new omics platform technology for systems biology and implications for natural products research. J. Nat. Prod., 2005, 68(12), 1813-1820.
19. Weckwerth, W. Metabolomics in systems biology. Annu. Rev. Plant Biol., 2003, 54, 669-689.
20. Natt, F. siRNAs in drug discovery: target validation and beyond. Curr. Opin. Mol. Ther., 2007, 9(3), 242-247.
21. Sachse, C.; Krausz, E.; Krönke, A.; Hannus, M.; Walsh, A.; Grabner, A.; Ovcharenko, D.; Dorris, D.; Trudel, C.; Sönnichsen, B.; Echeverri, C.J. High-throughput RNA interference strategies for target discovery and validation by using synthetic short-interfering RNAs: functional genomics investigations of biological pathways. Methods Enzymol., 2005, 392, 242-277.
22. Pepperkok, R.; Ellenberg, J. High-throughput fluorescence micros-copy for systems biology. Nat. Rev. Mol. Cell Biol., 2006, 7(9), 690-696.
23. Giuliano, K.A.; Johnston, P.A.; Gough, A.; Taylor, D.L. Systems cell biology based on high-content screening. Methods Enzymol., 2006, 414, 601-619.
24. Eggert, U.S.; Kiger, A.A.; Richter, C.; Perlman, Z.E.; Perrimon, N.; Mitchison, T.J.; Field, C.M. Parallel chemical genetic and genome-wide RNAi screens identify cytokinesis inhibitors and targets. PLoS Biol., 2004, 2(12), 2135-2143.
25. Gaither, L.A. Chemogenomics approaches to novel target discovery. Expert Rev. Proteomics, 2007, 4(3), 411-419.
26. Oprea, T.I.; Tropsha, A.; Faulon, J.L.; Rintoul, M.D. Systems chemical biology. Nat. Chem. Biol., 2007, 3(8), 447-450.
27. Rajasethupathy, P.; Vayttaden, S. J.; Bhalla, U.S. Systems modeling: a pathway to drug discovery. Curr. Opin. Chem. Biol., 2005, 9(4), 400-406
28. Young, D.W.; Bender, A.; Hoyt, J.; McWhinnie, E.; Chirn, G.W.; Tao, C.Y.; Tallarico, J.A.; Labow, M; Jenkins, J.L.; Mitchison, T.J.; Feng, Y. Integrating high-content screening and ligand-target prediction to identify mechanism of action. Nat. Chem. Biol., 2008, 4(1), 59-68.
29. Jensen, L.J.; Saric, J.; Bork P. Literature mining for the biologist: from information retrieval to biological discovery. Nat. Rev. Genet., 2006, 7(2),119-129.
30. Lamb, J.; Crawford, E.D.; Peck, D.; Modell, J.W.; Blat, I.C.; Wrobel, M.J.; Lerner, J.; Brunet, J.P.; Subramanian, A.; Ross, K.N.; Reich, M.; Hieronymus, H.; Wei, G.; Armstrong, S.A.; Haggarty, S.J.; Clemons, P.A.; Wei, R.; Carr, S.A.; Lander, E.S.; Golub, T.R. The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science, 2006, 313(5795),1929-1935.
31. Kanehisa, M.; Goto, S.; Furumichi, M.; Tanabe, M.; Hirakawa, M. KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Res., 2010, 38 (Database issue), D355-360.
32. Korn, K.; Krausz, E. Cell-based high-content screening of small-molecule libraries. Curr. Opin. Chem. Biol., 2007, 11 (5), 503-510
33. Giuliano, K.A.; DeBiasio, R.L.; Dunlay, R.T.; Gough, A.; Volosky, J.M.; Zock, J.; Pavlakis, G.N.; Taylor, D.L. High content screening: a new approach to easing key bottlenecks in the drug discovery process. J. Biomol. Screen., 1997, 2, 249-259.
34. Zock, J.M. Applications of high content screening in life science research. Comb. Chem. High Throughput. Screen, 2009, 12(9), 870-876.
35. Carpenter, A.E. Image-based chemical screening. Nat. Chem. Biol., 2007, 3(8), 461-465.
36. Lehár, J.; Stockwell, B.R.; Giaever, G.; Nislow, C. Combination chemical genetics. Nat. Chem. Biol., 2008, 4(11), 674-681.
37. Caponigro, G.; Abedi, M.R.; Hurlburt, A.P.; Maxfield, A.; Judd, W.; Kamb, A. Transdominant genetic analysis of a growth control pathway. Proc. Natl. Acad. Sci. USA, 1998, 95(13), 7508-7513.
38. Perlstein, E.O.; Ruderfer, D.M.; Ramachandran, G.; Haggarty, S.J.; Kruglyak, L.; Schreiber, S.L. Revealing complex traits with small molecules and naturally recombinant yeast strains. Chem. Biol., 2006, 13(3), 319-327.
39. Vaisberg, E.A.; Lenzi, D.; Hansen, R.L.; Keon, B.H.; Finer, J.T. An infrastructure for high-throughput microscopy: instrumentation, informatics, and integration. Methods Enzymol., 2006, 414, 484-512.
40. Anderson, D.G.; Putnam, D.; Lavik, E.B.; Mahmood, T.A.; Langer, R. Biomaterial microarrays: rapid, microscale screening of polymer-cell interaction. Biomaterials, 2005, 26(23), 4892-4897.
41. Ruiz, A.; Buzanska, L.; Gilliland, D.; Rauscher, H.; Sirghi, L.; Sobanski, T.; Zychowicz, M.; Ceriotti, L.; Bretagnol, F.; Coecke, S.; Colpo, P.; Rossi, F. Micro-stamped surfaces for the patterned growth of neural stem cells. Biomaterials, 2008, 29(36), 4766-4774.
42. Ochsner, M.; Dusseiller, M.R.; Grandin, H.M.; Luna-Morris, S.; Textor, M.; Vogel, V.; Smith, M.L. Micro-well arrays for 3D shape control and high resolution analysis of single cells. Lab. Chip., 2007, 7(8), 1074-1077.
43. Engler, A.J.; Sen, S.; Sweeney, H.L.; Discher, D.E. Matrix elasticity directs stem cell lineage specification. Cell, 2006, 126(4), 677-689.
44. Even-Ram, S.; Artym, V.; Yamada, K.M. Matrix control of stem cell fate. Cell, 2006, 126(4), 645-647.
45. Giuliano, K.A.; Taylor, D.L.; Waggoner, A.S. Reagents to measure and manipulate cell functions. Methods Mol. Biol., 2007, 356, 141-163.
46. Abraham, V.C.; Taylor, D.L.; Haskins, J.R. High content screening applied to large-scale cell biology. Trends Biotechnol., 2004, 22(1), 15-22.
47. O'Brien, J. P.; Haskins, J.R. in vitro cytotoxicity assessment. In: High Content Screening: A powerful Approach to Systems Cell Biology and Drug Discovery; Humana Press: Totowa, NJ, 2006, pp. 415-426.
48. Wolff, M.; Wiedenmann, J.; Nienhaus, G.U.; Valler, M.; Heilker, R. Novel fluorescent proteins for high-content screening. Drug Discov. Today, 2006, 11(23-24), 1054-1060.
49. Chudakov, D.M.; Lukyanov, K.A. Use of green fluorescent protein (GFP) and its homologs for in vivo protein motility studies. Biochemistry, (Mosc) 2003, 68(9), 952-957.
50. Wu, X.; Liu, H.; Liu, J.; Haley, K.N.; Treadway, J.A.; Larson, J.P.; Ge, N.; Peale, F.; Bruchez, M.P. Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots. Nat. Biotechnol., 2003, 21(1), 41-62.
51. Jaiswal, J.K.; Mattoussi, H.; Mauro, J. M.; Simon, S.M. Long-term multiple color imaging of live cells using quantum dot bioconjugates. Nat. Biotechnol., 2003, (1), 47-51.
52. Kwok, T.C.; Ricker, N.; Fraser, R.; Chan, A.W.; Burns, A.; Stanley, E.F.; McCourt, P.; Cutler, S.R.; Roy, P.J. A small-molecule screen in C. elegans yields a new calcium channel antagonist. Nature, 2006, 441, 91-95.
53. Spring, D.R.; Krishnan, S.; Blackwell, H. E.; Schreiber, S.L. Diversity-oriented synthesis of biaryl-containing medium rings using a one bead/one stock solution platform. J. Am. Chem. Soc., 2002, 124(7), 1354-1363.
54. Peterson, R.T.; Shaw, S.Y.; Peterson, T.A.; Milan, D.J.; Zhong, T.P.; Schreiber, S.L.; MacRae, C.A.; Fishman, M.C. Chemical suppression of a genetic mutation in a zebrafish model of aortic coarctation. Nat. Biotechnol., 2004, 22(5), 595-599.
55. Stern, H.M.; Murphey, R.D.; Shepard, J.L.; Amatruda, J.F.; Straub, C.T.; Pfaff, K.L.; Weber, G.; Tallarico, J.A.; King, R.W.; Zon, L.I. Small molecules that delay S phase suppress a zebrafish bmyb mutant. Nat. Chem. Biol., 2005, 1(7), 366-370.
56. Kassner, P.D. Discovery of novel targets with high throughput RNA interference screening. Comb. Chem. High Throughput Screen, 2008, 11(3), 175-184.
57. Fedorov, Y.; Anderson, E.M.; Birmingham, A.; Reynolds, A.; Karpilow, J.; Robinson, K.; Leake, D.; Marshall, W.S.; Khvorova, A. Off-target effects by siRNA can induce toxic phenotype. RNA, 2006, 12(7), 1188-1196.
58. Lin, X.; Ruan, X.; Anderson, M. G.; McDowell, J. A.; Kroeger, P. E.; Fesik, S.W.; Shen, Y. siRNA-mediated off-target gene silencing triggered by a 7 nt complementation. Nucleic Acids Res., 2005, 33(14), 4527-4535.
59. Li, L.; Lin, X.; Shoemaker, A.R.; Albert, D.H.; Fesik, S.W.; Shen, Y. Hypoxia-inducible factor-1 inhibition in combination with temozolomide treatment exhibits robust antitumor efficacy in vivo. Clin. Cancer Res., 2006, 12(15), 4747-4754.
60. Martin, R.; Lahlil, R.; Damert, A.; Miquerol, L.; Nagy, A.; Keller, G.; Hoang, T. SCL interacts with VEGF to suppress apoptosis at the onset of hematopoiesis. Development, 2004, 131(3), 693-702.
61. Gambello, M.J.; Darling, D.L.; Yingling, J.; Tanaka, T.; Gleeson, J.G.; Wynshaw-Boris, A. Multiple dose-dependent effects of Lis1 on cerebral cortical development. J. Neurosci., 2003, 23(5), 1719-1729.
62. MacDonald, B.T.; Adamska, M.; Meisler, M.H. Hypomorphic expression of Dkk1 in the doubleridge mouse: dose dependence and compensatory interactions with Lrp6. Development, 2004, 1(11), 2543-2552.
63. Levitt, P.S.; Zhu, M.; Cassano, A.; Yazinski, S.A.; Liu, H.; Darfler, J.; Peters, R.M.; Weiss, R.S. Genome maintenance defects in cultured cells and mice following partial inactivation of the essential cell cycle checkpoint gene Hus1. Mol. Cell Biol., 2007, 27(6), 2189-2201.
64. Liu, X.; Lei, M.; Erikson, R.L. Normal cells, but not cancer cells, survive severe Plk1 depletion. Mol. Cell Biol., 2006, 26(6), 2093-2108.
65. Hemann, M.T.; Fridman, J.S.; Zilfou, J.T.; Hernando, E.; Paddison, P.J.; Cordon-Cardo, C.; Hannon, G. J.; Lowe, S.W. An epi-allelic series of p53 hypomorphs created by stable RNAi produces distinct tumor phenotypes in vivo. Nat. Genet., 2003, 33, 396-400.
66. Jones, T.R.; Kang, I. H.; Wheeler, D.B.; Lindquist, R.A.; Papallo, A.; Sabatini, D.M.; Golland, P.; Carpenter, A. E. CellProfiler Analyst: data exploration and analysis software for complex image-based screens. BMC Bioinformatics, 2008, 15(9), 482.
67. Jones, T.R.; Carpenter, A.E.; Lamprecht, M.R.; Moffat, J.; Silver, S.J.; Grenier, J.K.; Castoreno, A.B.; Eggert, U.S.; Root, D.E.; Golland, P.; Sabatini, D.M. Scoring diverse cellular morphologies in image-based screens with iterative feedback and machine learning. Proc. Natl. Acad. Sci. USA, 2009, 106(6), 1826-1831.
68. Kaiser, M.; Wetzel, S.; Kumar, K.; Waldmann, H. Biology-inspired synthesis of compound libraries. Cell Mol. Life Sci., 2008, 65(7-8), 1186-1201.
69. Shim, J.S.; Kwon, H. J. Chemical genetics for therapeutic target mining. Expert Opin. Ther. Targets, 2004, 8(6), 653-661.
70. Schreiber, S.L. Chemical genetics resulting from a passion for synthetic organic chemistry. Bioorg. Med. Chem., 1998, 6(8), 1127-1152.
71. Zhang, L.; Yu, J.; Pan, H.; Hu, P.; Hao, Y.; Cai, W.; Zhu, H.; Yu, A.D.; Xie, X.; Ma, D.; Yuan, J. Small molecule regulators of autophagy identified by an image-based high-throughput screen. Proc. Natl. Acad. Sci. USA, 2007, 104(48), 19023-19028.
72. Zanella, F.; Rosado, A.; García, B.; Carnero, A.; Link, W. Chemical genetic analysis of FOXO nuclear-cytoplasmic shuttling by using image-based cell screening. Chembiochem., 2008, 9(14), 2229-2237.
73. Stern, H.M.; Murphey, R.D.; Shepard, J.L.; Amatruda, J.F.; Straub, C.T.; Pfaff, K.L.; Weber, G.; Tallarico, J.A.; King, R.W.; Zon, L.I. Small molecules that delay S phase suppress a zebrafish bmyb mutant. Nat. Chem. Biol., 2005, 1(7), 366-370.
74. Tanaka, M.; Bateman, R.; Rauh, D.; Vaisberg, E.; Ramachandani, S.; Zhang, C.; Hansen, K.C.; Burlingame, A.L.; Trautman, J.K.; Shokat, K.M.; Adams, C.L. An unbiased cell morphology-based screen for new, biologically active small molecules. PLoS Biol., 2005, 3(5), 764-775.
75. Loo, L.H.; Wu, L.F.; Altschuler, S.J. Image-based multivariate profiling of drug responses from single cells. Nat. Methods, 2007, 4(5), 445-453.
76. Schena, M.; Shalon, D.; Heller, R.; Chai, A.; Brown, P.O.; Davis, R.W. Parallel human genome analysis: microarray-based expression monitoring of 1000 genes. Proc. Natl. Acad. Sci. USA, 1996, 93(20), 10614-10619.
77. Lockhart, D.J.; Dong, H.; Byrne, M.C.; Follettie, M.T.; Gallo, M.V.; Chee, M.S.; Mittmann, M.; Wang, C.; Kobayashi, M.; Horton, H.; Brown, E.L. Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat. Biotechnol., 1996, 13, 1675-1680.
78. Canales, R.D.; Luo, Y.; Willey, J.C.; Austermiller, B.; Barbacioru, C.C.; Boysen, C.; Hunkapiller, K.; Jensen, R.V.; Knight, C.R.; Lee, K.Y.; Ma, Y.; Maqsodi, B.; Papallo, A.; Peters, E.H.; Poulter, K.; Ruppel, P.L.; Samaha, R.R.; Shi, L.; Yang, W.; Zhang, L.; Goodsaid, F.M. Evaluation of DNA microarray results with quantitative gene expression platforms. Nat. Biotechnol., 2006, 24(9), 1115-1122
79. Li, Z.; Su, Z.; Wen, Z.; Shi, L.; Chen, T. Microarray platform consistency is revealed by biologically functional analysis of gene expression profiles. BMC Bioinformatics, 2009, 10 (Suppl 11), S12.
80. Cheadle, C.; Becker, K.G.; Cho-Chung, Y.S.; Nesterova, M.; Watkins, T.; Wood, W 3rd.; Prabhu, V.; Barnes, K.C. A rapid method for microarray cross platform comparisons using gene expression signatures. Mol. Cell. Probes, 2009, 1, 35-46.
81. Jurata, L.W.; Bukhman, Y.V.; Charles, V.; Capriglione, F.; Bullard, J.; Lemire, A.L.; Mohammed, A.; Pham, Q.; Laeng, P.; Brockman, J.A.; Altar, C.A. Comparison of microarray-based mRNA profiling technologies for identification of psychiatric disease and drug signatures. J. Neurosci. Methods, 2004, 138(1-2), 173-188.
82. Pedotti, P.; 't Hoen, P.A.; Vreugdenhil, E.; Schenk, G.J.; Vossen, R.H.; Ariyurek, Y.; de Hollander, M.; Kuiper, R.; van Ommen, G. J.; den Dunnen, J.T.; Boer, J.M.; de Menezes, R.X. Can subtle changes in gene expression be consistently detected with different microarray platforms? BMC Genomics, 2008, 9, 124.
83. Ha, KCh.; Coulombe-Huntington, J.; Majewski, J. Comparison of Affymetrix Gene Array with the Exon Array shows potential application for detection of transcript isoform variation. BMC Genomics, 2009, 10, 519.
84. Shen, S.; Warzecha, C.C.; Carstens, R.P.; Xing, Y. MADS+: discovery of differential splicing events from Affymetrix exon junction array data. Bioinformatics, 2009, 26(2), 268-269.
85. Chen, Y.; Gelfond, J.A.; McManus, L.M.; Shireman, P.K. Reproducibility of quantitative RT-PCR array in miRNA expression profiling and comparison with microarray analysis. BMC Genomics, 2009, 10, 407.
86. Sato, F.; Tsuchiya, S.; Terasawa, K.; Tsujimoto, G. Intra-platform repeatability and inter-platform comparability of microRNA microarray technology. PLoS One, 2009, 4(5), e5540.
87. Spurgeon, S.L.; Jones, R.C.; Ramakrishnan, R. High throughput gene expression measurement with real time PCR in a microfluidic dynamic array. PLoS One, 2008, 3(2), e1662.
88. Diercks, A.; Kostner, H.; Ozinsky, A. Resolving cell population heterogeneity: real-time PCR for simultaneous multiplexed gene detection in multiple single-cell samples. PLoS One, 2009, 4(7), e6326.
89. Diehn, M.; Cho, R.W.; Lobo, N.A.; Kalisky, T.; Dorie, M.J.; Kulp, A.N.; Qian, D.; Lam, J.S.; Ailles, L.E.; Wong, M.; Joshua, B.; Kaplan, M.J.; Wapnir, I.; Dirbas, F.M.; Somlo, G.; Garberoglio, C.; Paz, B.; Shen, J.; Lau, S.K.; Quake, S.R.; Brown, J.M.; Weissman, I.L.; Clarke, M.F. Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature, 2009, 458, 780-783.
90. Dehnhardt, C.M.; Venkatesan, A.M.; Chen, Z.; Ayral-Kaloustian, S.; Dos Santos, O.; Delos Santos, E.; Curran, K.; Follettie, M.T.; Diesl, V.; Lucas, J.; Geng, Y.; Dejoy, S.Q.; Petersen, R.; Chaudhary, I.; Brooijmans, N.; Mansour, T.S.; Arndt, K.; Chen, L. Design and synthesis of novel diaminoquinazolines with in vivo efficacy for beta-catenin/T-cell transcriptional factor 4 pathway inhibition. J. Med. Chem., 2010, 53(2), 897-910.
91. Follettie, M.T.; Pinard, M.; Keith, J.C Jr.; Wang, L.; Chelsky, D.; Hayward, C.; Kearney, P.; Thibault, P.; Paramithiotis, E.; Dorner, A.J.; Harris, H.A. Organ messenger ribonucleic acid and plasma proteome changes in the adjuvant-induced arthritis model: responses to disease induction and therapy with the estrogen receptor-beta selective agonist ERB-041. Endocrinology, 2006, 147(2), 714-723.
92. Kier, L.D.; Neft, R.; Tang, L.; Suizu, R.; Cook, T.; Onsurez, K.; Tiegler, K.; Sakai, Y.; Ortiz, M.; Nolan, T.; Sankar, U.; Li, A.P. Applications of microarrays with toxicologically relevant genes (tox genes) for the evaluation of chemical toxicants in Sprague Dawley rats in vivo and human hepatocytes in vitro. Mutat. Res., 2004, 549(1-2), 101-113.
93. Burczynski, M.E. Pharmacogenomic approaches in clinical studies to identify biomarkers of safety and efficacy. Toxicol. Lett., 2009, 186(1), 18-21.
94. Golub, T. R.; Slonim, D.K.; Tamayo, P.; Huard, C.; Gaasenbeek, M.; Mesirov, J.P.; Coller, H.; Loh, M.L.; Downing, J.R.; Caligiuri, M.A.; Bloomfield, C.D.; Lander, E.S. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science, 1999, 286(5439), 531-537.
95. Sørlie, T.; Perou, C.M.; Tibshirani, R.; Aas, T.; Geisler, S.; Johnsen, H.; Hastie, T.; Eisen, M.B.; van de Rijn, M.; Jeffrey, S.S.; Thorsen, T.; Quist, H.; Matese, J.C.; Brown, P.O.; Botstein, D.; Eystein Lønning, P.; Børresen-Dale, A.L. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl. Acad. Sci. USA, 2001, 98(19), 10869-10874.
96. Verhaak, R.G.; Hoadley, K.A.; Purdom, E.; Wang, V.; Qi, Y.; Wilkerson, M.D.; Miller, C.R.; Ding, L.; Golub, T.; Mesirov, J.P.; Alexe, G.; Lawrence, M.; O'Kelly, M.; Tamayo, P.; Weir, B.A.; Gabriel, S.; Winckler, W.; Gupta, S.; Jakkula, L.; Feiler, H.S.; Hodgson, J.G.; James, C.D.; Sarkaria, J.N.; Brennan, C.; Kahn, A.; Spellman, P.T.; Wilson, R.K.; Speed, T.P.; Gray, J.W.; Meyerson, M.; Getz, G.; Perou, C.M.; Hayes, D.N. Cancer Genome Atlas Research Network. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell, 2010, 17(1), 98-110.
97. Storey, J.D.; Tibshirani, R. Statistical methods for identifying differentially expressed genes in DNA microarrays. Methods Mol. Biol., 2003, 224, 149-157.
98. Eisen, M.B.; Spellman, P.T.; Brown, P.O.; Botstein, D. Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. USA, 1998, 95(25), 14863-14868.
99. Harris, M.A.; Clark, J.; Ireland, A.; Lomax, J.; Ashburner, M.; Foulger, R.; Eilbeck, K.; Lewis, S.; Marshall, B.; Mungall, C.; Richter, J.; Rubin, G.M.; Blake, J.A.; Bult, C.; Dolan, M.; Drabkin, H.; Eppig, JT.; Hill, D.P.; Ni, L.; Ringwald, M.; Balakrishnan, R.; Cherry, J.M.; Christie, K.R.; Costanzo, M.C.; Dwight, S.S.; Engel, S.; Fisk, D.G.; Hirschman, J.E.; Hong, E.L.; Nash, R.S.; Sethuraman, A.; Theesfeld, C.L.; Botstein, D.; Dolinski, K.; Feierbach, B.; Berardini, T.; Mundodi, S.; Rhee, S.Y.; Apweiler, R.; Barrell, D.; Camon, E.; Dimmer, E.; Lee, V.; Chisholm, R.; Gaudet, P.; Kibbe, W.; Kishore, R.; Schwarz, E.M.; Sternberg, P.; Gwinn, M.; Hannick, L.; Wortman, J.; Berriman, M.; Wood, V.; de la Cruz, N.; Tonellato, P.; Jaiswal, P.; Seigfried, T.; White, R. Gene Ontology Consortium. The Gene Ontology (GO) database and informatics resource. Nucleic Acids Res., 2004, 32, D258-261.
100. Mootha, V.K.; Lindgren, C.M.; Eriksson, K.F.; Subramanian, A.; Sihag, S.; Lehar, J.; Puigserver, P.; Carlsson, E.; Ridderstråle, M.; Laurila, E.; Houstis, N.; Daly, M.J.; Patterson, N.; Mesirov, J.P.; Golub, T.R.; Tamayo, P.; Spiegelman, B.; Lander, E.S.; Hirschhorn, J.N.; Altshuler, D.; Groop, L.C. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet., 2003, 34(3), 267-273.
101. Rhodes, D.R.; Barrette, T.R.; Rubin, M.A.; Ghosh, D.; Chinnaiyan, A. M. Meta-analysis of microarrays: interstudy validation of gene expression profiles reveals pathway dysregulation in prostate cancer Cancer Res., 2002, 62(15), 4427-4433.
102. Rhodes, D.R.; Yu, J.; Shanker, K.; Deshpande, N.; Varambally, R.; Ghosh, D.; Barrette, T.; Pandey, A.; Chinnaiyan, A.M. Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression. Proc. Natl. Acad. Sci. USA, 2004, 101(25), 9309-9314.
103. Thomassen, M.; Tan, Q.; Kruse, T.A. Gene expression meta-analysis identifies metastatic pathways and transcription factors in breast cancer. BMC Cancer, 2008, 8, 394.
104. Peri, S.; Navarro, J.D.; Amanchy, R.; Kristiansen, T.Z.; Jonnalagadda, C.K.; Surendranath, V.; Niranjan, V.; Muthusamy, B.; Gandhi, T.K.; Gronborg, M.; Ibarrola, N.; Deshpande, N.; Shanker, K.; Shivashankar, H.N.; Rashmi, B.P.; Ramya, M.A.; Zhao, Z.; Chandrika, K.N.; Padma, N.; Harsha, H.C.; Yatish, A.J.; Kavitha, M.P.; Menezes, M.; Choudhury, D.R.; Suresh, S.; Ghosh, N.; Saravana, R.; Chandran, S.; Krishna, S.; Joy, M.; Anand, S.K.; Madavan, V.; Joseph, A.; Wong, G.W.; Schiemann, W.P.; Constantinescu, S.N.; Huang, L.; Khosravi-Far, R.; Steen, H.; Tewari, M.; Ghaffari, S.; Blobe, G.C.; Dang, C.V.; Garcia, J.G.; Pevsner, J.; Jensen, O.N.; Roepstorff, P.; Deshpande, K.S.; Chinnaiyan, A.M.; Hamosh, A.; Chakravarti, A.; Pandey, A. Development of human protein reference database as an initial platform for approaching systems biology in humans. Genome Res., 2003, 13(10), 2363-2371.
105. Carro, M.S.; Lim, W.K.; Alvarez, M.J.; Bollo, R.J.; Zhao, X.; Snyder, E.Y.; Sulman, E.P.; Anne, S.L.; Doetsch, F.; Colman, H.; Lasorella, A.; Aldape, K.; Califano, A.; Iavarone, A. The transcriptional network for mesenchymal transformation of brain tumours. Nature, 2010, 463(7279), 318-325.
106. Velculescu, V.E.; Zhang, L.; Vogelstein, B.; Kinzler, K.W. Serial analysis of gene expression. Science, 1995, 270(5235), 484-487.
107. Wang, Z.; Gerstein, M.; Snyder, M. RNA-Seq: a revolutionary tool for transcriptomics. Nat. Rev. Genet., 2009, 10(1), 57-63.
108. Nagalakshmi, U.; Wang, Z.; Waern, K.; Shou, C.; Raha, D.; Gerstein, M.; Snyder, M. The transcriptional landscape of the yeast genome defined by RNA sequencing. Science, 2008, 320(5881), 1344-1349.
109. Greenbaum, D.; Colangelo, C.; Williams, K.; Gerstein, M. Comparing protein abundance and mRNA expression levels on a genomic scale. Genome Biol., 2003, 4(9), 117.
110. Domon, B.; Aebersold, R. Mass spectrometry and protein analysis. Science, 2006, 312(5771), 212-217.
111. Fenn, J.B. Electrospray ionization for mass spectrometry of large biomolecules. Science, 1989, 246(4926), 64-71.
112. Karas, M.; Hillenkamp, F. Laser desorption ionization of proteins with molecular masses exceeding 10,000 daltons. Anal. Chem., 1988, 60(20), 2299-2301.
113. Link, A.J. Direct analysis of protein complexes using mass spectrometry. Nat. Biotechnol., 1999, 17(7), 676-682.
114. Syka, J.E. Peptide and protein sequence analysis by electron transfer dissociation mass spectrometry. Proc. Natl. Acad. Sci. USA, 2004, 101(26), 9528-9533.
115. Hardman, M.; Makarov A.A. Interfacing the orbitrap mass analyzer to an electrospray ion source. Anal. Chem., 2003, 75(7), 1699-6705.
116. Eng, J.K.; McCormack, A.L.; Yates, J.R. An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database. J. Am. Soc. Mass Spectrometry, 1994, 5(11), 976-989.
117. Perkins, D.N. Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis, 1999, 20(18), 3551-3567.
118. Ong, S.E. Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol. Cell Proteomics, 2002, 1(5), 376-386.
119. Gygi, S.P. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat. Biotechnol., 1999, 17(10), 994-999.
120. Ross, P.L. Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol. Cell Proteomics, 2004, 3(12), 1154-1169.
121. Yao, X. Proteolytic 18O labeling for comparative proteomics: model studies with two serotypes of adenovirus. Anal. Chem., 2001, 73(13), 2836-2842.
122. Wang, W.; Zhou, H.; Lin, H.; Roy, S.; Shaler, T. A.; Hill, L. R.; Norton, S.; Kumar, P.; Anderle, M.; Becker, C. H. Quantification of proteins and metabolites by mass spectrometry without isotopic labeling or spiked standards. Anal. Chem., 2003, 75, 4818-4826.
123. Wollscheid, B.; Bausch-Fluck, D.; Henderson, C.; O'Brien, R.; Bibel, M.; Schiess, R.; Aebersold, R.; Watts, J. D. Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins. Nat. Biotechnol., 2009, 27, 378-386.
124. Pandey, A.; Fernandez, M. M.; Steen, H.; Blagoev, B.; Nielsen, M. M.; Roche, S.; Mann, M.; Lodish, H. F. Identification of a novel immunoreceptor tyrosine-based activation motif-containing molecule, STAM2, by mass spectrometry and its involvement in growth factor and cytokine receptor signaling pathways. J. Biol. Chem., 2000, 275, 38633-38639.
125. Corthals, G. L.; Aebersold, R.; Goodlett, D. R. Identification of phosphorylation sites using microimmobilized metal affinity chromatography. Methods Enzymol., 2005, 405, 66-81.
126. Ficarro, S. B.; McCleland, M. L.; Stukenberg, P. T.; Burke, D. J.; Ross, M. M.; Shabanowitz, J.; Hunt, D. F.; White, F. M. Phosphoproteome analysis by mass spectrometry and its application to Saccharomyces cerevisiae. Nat. Biotechnol., 2002, 20, 301-305.
127. Pinkse, M. W.; Uitto, P. M.; Hilhorst, M. J.; Ooms, B.; Heck, A. J. Selective isolation at the femtomole level of phosphopeptides from proteolytic digests using 2D-NanoLC-ESI-MS/MS and titanium oxide precolumns. Anal. Chem., 2004, 76, 3935-3943.
128. Kruger, M.; Kratchmarova, I.; Blagoev, B.; Tseng, Y. H.; Kahn, C. R.; Mann, M. Dissection of the insulin signaling pathway via quantitative phosphoproteomics. Proc. Natl. Acad. Sci. USA, 2008, 105, 2451-2456.
129. Wu, J.; Shakey, Q.; Liu, W.; Schuller, A.; Follettie, M. T. Global profiling of phosphopeptides by titania affinity enrichment. J. Proteome Res., 2007, 6, 4684-4689.
130. Wolf-Yadlin, A.; Hautaniemi, S.; Lauffenburger, D. A.; White, F. M. Multiple reaction monitoring for robust quantitative proteomic analysis of cellular signaling networks. Proc. Natl. Acad. Sci. USA, 2007, 104, 5860-5865.
131. Zubarev, R. A.; Horn, D. M.; Fridriksson, E. K.; Kelleher, N. L.; Kruger, N. A.; Lewis, M. A.; Carpenter, B. K.; McLafferty, F.W. Electron capture dissociation for structural characterization of multiply charged protein cations. Anal. Chem., 2000, 72, 563-573.
132. Syka, J. E.; Coon, J. J.; Schroeder, M. J.; Shabanowitz, J.; Hunt, D. F. Peptide and protein sequence analysis by electron transfer dissociation mass spectrometry. Proc. Natl. Acad. Sci. USA, 2004, 101, 9528-9533.
133. Wu, L.; Hwang, S. I.; Rezaul, K.; Lu, L. J.; Mayya, V.; Gerstein, M.; Eng, J. K.; Lundgren, D. H.; Han, D. K. Global survey of human T leukemic cells by integrating proteomics and transcriptomics profiling. Mol. Cell Proteomics, 2007, 6, 1343-1353.
134. Ong, S. E.; Blagoev, B.; Kratchmarova, I.; Kristensen, D. B.; Steen, H.; Pandey, A.; Mann, M. Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol. Cell Proteomics, 2002, 1, 376-386.
135. Huang, S.M.; Mishina, Y.M.; Liu, S.; Cheung, A.; Stegmeier, F.; Michaud, G.A.; Charlat, O.; Wiellette, E.; Zhang, Y.; Wiessner, S.; Hild, M.; Shi, X.; Wilson, C.J.; Mickanin, C.; Myer, V.; Fazal, A.; Tomlinson, R.; Serluca, F.; Shao, W.; Cheng, H.; Shultz, M.; Rau, C.; Schirle, M.; Schlegl, J.; Ghidelli, S.; Fawell, S.; Lu, C.; Curtis, D.; Kirschner, M.W.; Lengauer, C.; Finan, P.M.; Tallarico, J.A.; Bouwmeester, T.; Porter, J.A.; Bauer, A.; Cong, F. Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling. Nature, 2009, 461(7264), 614-620.
136. Rao, Y.; Lee, Y.; Jarjoura, D.; Ruppert, A.S.; Liu, C.G.; Hsu, J.C.; Hagan, J.P. A comparison of normalization techniques for microRNA microarray data. Stat. Appl. Genet. Mol. Biol., 2008, 7(1), Article22.
137. Pearson, K. On Lines and Planes of Closest Fit to Systems of Points in Space. Philos. Mag., 1901, 2 (6), 559-572.
138. Subramanian, A.; Tamayo, P.; Mootha, V.K.; Mukherjee, S.; Ebert, B.L.; Gillette, M.A.; Paulovich, A.; Pomeroy, S.L.; Golub, T.R.; Lander, E.S.; Mesirov, J.P. Gene set enrichmentanalysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA, 2005, 102(43), 15545-15550.
139. Wingender, E.; Dietze, P.; Karas, H.; Knüppel, R. TRANSFAC: a database on transcription factors and their DNA binding sites. Nucleic Acids Res., 1996, 24(1), 238-241.
140. Hucka, M.; Finney, A.; Sauro, H.M.; Bolouri, H.; Doyle, J.C.; Kitano, H.; Arkin, A.P.; Bornstein, B.J.; Bray, D.; Cornish-Bowden, A.; Cuellar, A.A.; Dronov, S.; Gilles, E.D.; Ginkel, M.; Gor, V.; Goryanin, I.I.; Hedley, W.J.; Hodgman, T.C. Hofmeyr, J.H.; Hunter, P.J.; Juty, N.S.; Kasberger, J.L.; Kremling, A.; Kummer, U.; Le Novère, N.; Loew, L.M.; Lucio, D.; Mendes, P.; Minch, E.; Mjolsness, E.D.; Nakayama, Y.; Nelson, M.R.; Nielsen, P.F.; Sakurada, T.; Schaff, J.C.; Shapiro, B.E.; Shimizu, T.S.; Spence, H.D.; Stelling, J.; Takahashi, K.; Tomita, M.; Wagner, J.; Wang, J. SBML Forum. The systems biology markup language (SBML): a medium for representation and exchange of biochemical network models. Bioinformatics, 2003, 19(4), 524-531.
141. Shannon, P.; Markiel, A.; Ozier, O.; Baliga, N.S.; Wang, J.T.; Ramage, D.; Amin, N.; Schwikowski, B.; Ideker, T. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res., 2003, 13(11), 2498-2504.